Vaderis Therapeutics AG
2 clinical trials · Sponsor
◉ Watch Vaderis Therapeutics AG
| Record | Firm | Date |
|---|---|---|
| A Trial to Assess the Efficacy and Safety of Engasertib in Participants With Moderate to Severe Hereditary Hemorrhagic Telangiectasia (HHT) (NCT07743671) | Vaderis Therapeutics AG | 2026-09-01 |
| Assess Safety and Efficacy of VAD044 in HHT Patients (NCT05406362) | Vaderis Therapeutics AG | 2022-07-18 |
Track Vaderis Therapeutics AG automatically
Every clearance here is in the API, with alerts when new ones post.